Skip to main content
Top
Published in: Clinical Rheumatology 5/2011

01-05-2011 | Case Based Review

Syphilitic myositis: a case-based review

Authors: Elaine Yacyshyn, Praveena Chiowchanwisawakit, Derek J. Emery, Jack Jhamandas, Lothar Resch, Geoffrey Taylor

Published in: Clinical Rheumatology | Issue 5/2011

Login to get access

Abstract

To present the clinical and pathological findings in patients presenting with myositis caused by syphilis. The literature is reviewed, and pathophysiologic factors discussed. A 49-year-old Caucasian heterosexual male with a known history of stable human immunodeficiency virus (HIV) and hepatitis C (HCV) co-infection, developed progressive muscle weakness over 10 weeks. He discontinued his medications; however, he had on-going muscle symptoms. A muscle biopsy was performed, consistent with mild myositis. While on prednisone therapy, he developed panuveitis and vertigo. CSF studies were positive for syphilis (Treponema pallidum). He was started on appropriate antibiotic therapy with complete clinical resolution. This patient presented with myositis and panuveitis as a manifestation of acute onset of syphilis. Syphilis is an uncommon cause of myositis. In patients with HIV and/or HCV, the disease itself and side effects of the medications must be considered. As patients with HIV may have co-infections, syphilis must be considered, especially when unresponsive to traditional management.
Literature
1.
go back to reference Authier FJ, Chariot P, Gherardi RK (2005) Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 32(3):247–260PubMedCrossRef Authier FJ, Chariot P, Gherardi RK (2005) Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 32(3):247–260PubMedCrossRef
2.
go back to reference Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD (2003) Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 49(2):172–178PubMedCrossRef Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD (2003) Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum 49(2):172–178PubMedCrossRef
3.
go back to reference Basu D, Williams FM, Ahn CW, Reveille JD (2006) Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 55(3):466–472PubMedCrossRef Basu D, Williams FM, Ahn CW, Reveille JD (2006) Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 55(3):466–472PubMedCrossRef
4.
go back to reference Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, Solomon GE, Winchester R (1990) A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 112(1):3–10PubMed Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, Solomon GE, Winchester R (1990) A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med 112(1):3–10PubMed
5.
go back to reference Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322(16):1098–1105PubMedCrossRef Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322(16):1098–1105PubMedCrossRef
6.
go back to reference Reveille JD (2005) Inflammatory diseases of muscle and other myopathies. In: Kelly W, Harris E, Budd R, Firestein G et al (eds) Kelly's Textbook of Rheumatology, vol 2, 7th edn. Saunders, Philadelphia, pp 1664–1666 Reveille JD (2005) Inflammatory diseases of muscle and other myopathies. In: Kelly W, Harris E, Budd R, Firestein G et al (eds) Kelly's Textbook of Rheumatology, vol 2, 7th edn. Saunders, Philadelphia, pp 1664–1666
7.
go back to reference Medina F, Perez-Saleme L, Moreno J (2006) Rheumatic manifestations of Human Immunodeficiency Virus infection. Infect Dis Clin N Am 20:891–912CrossRef Medina F, Perez-Saleme L, Moreno J (2006) Rheumatic manifestations of Human Immunodeficiency Virus infection. Infect Dis Clin N Am 20:891–912CrossRef
9.
go back to reference Venezia G, Licata A, Di Marco V, Craxi A, Almasio PL (2005) Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Dig Liver Dis 37(11):882–885PubMedCrossRef Venezia G, Licata A, Di Marco V, Craxi A, Almasio PL (2005) Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Dig Liver Dis 37(11):882–885PubMedCrossRef
10.
go back to reference Ito H, Ito H, Nagano M, Nakano S, Shigeyoshi Y, Kusaka H (2005) In situ identification of hepatitis C virus RNA in muscle. Neurology 64(6):1073–1075PubMed Ito H, Ito H, Nagano M, Nakano S, Shigeyoshi Y, Kusaka H (2005) In situ identification of hepatitis C virus RNA in muscle. Neurology 64(6):1073–1075PubMed
11.
go back to reference Satoh J, Eguchi Y, Narukiyo T et al (2000) Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature. Intern Med 39(2):176–181PubMedCrossRef Satoh J, Eguchi Y, Narukiyo T et al (2000) Necrotizing myopathy in a patient with chronic hepatitis C virus infection: a case report and a review of the literature. Intern Med 39(2):176–181PubMedCrossRef
12.
go back to reference Di Muzio A, Bonetti B, Capasso M et al (2003) Hepatitis C virus infection and myositis: a virus localization study. Neuromuscul Disord 13(1):68–71PubMedCrossRef Di Muzio A, Bonetti B, Capasso M et al (2003) Hepatitis C virus infection and myositis: a virus localization study. Neuromuscul Disord 13(1):68–71PubMedCrossRef
13.
go back to reference Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39(1):2–17PubMedCrossRef Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB (2007) Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39(1):2–17PubMedCrossRef
14.
go back to reference Warabi Y, Matsubara S, Mizutani T, Hayashi H (2004) Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection. Rinsho Shinkeigaku 44(9):609–614PubMed Warabi Y, Matsubara S, Mizutani T, Hayashi H (2004) Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection. Rinsho Shinkeigaku 44(9):609–614PubMed
15.
go back to reference Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW (1995) Polymyositis, pulmonary fibrosis, and hepatitis. C Arthritis Rheum 38(3):437–439CrossRef Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW (1995) Polymyositis, pulmonary fibrosis, and hepatitis. C Arthritis Rheum 38(3):437–439CrossRef
16.
go back to reference Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T (1995) Hepatitis C infection and polymyositis. Lancet 346(8970):319–320PubMedCrossRef Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T (1995) Hepatitis C infection and polymyositis. Lancet 346(8970):319–320PubMedCrossRef
17.
go back to reference Matsuya M, Abe T, Tosaka M, Yonezawa K, Ono A, Ikeda N, Yoshida Y, Akahonai Y, Kurokawa S, Hayashi T et al (1994) The first case of polymyositis associated with interferon therapy. Intern Med 33(12):806–808PubMedCrossRef Matsuya M, Abe T, Tosaka M, Yonezawa K, Ono A, Ikeda N, Yoshida Y, Akahonai Y, Kurokawa S, Hayashi T et al (1994) The first case of polymyositis associated with interferon therapy. Intern Med 33(12):806–808PubMedCrossRef
18.
go back to reference Cirigliano G, Della Rossa A, Tavoni A, Viacava P, Bombardieri S (1999) Polymyositis occurring during alpha-interferon treatment for malignant melanoma: a case report and review of the literature. Rheumatol Int 19(1–2):65–67PubMedCrossRef Cirigliano G, Della Rossa A, Tavoni A, Viacava P, Bombardieri S (1999) Polymyositis occurring during alpha-interferon treatment for malignant melanoma: a case report and review of the literature. Rheumatol Int 19(1–2):65–67PubMedCrossRef
19.
go back to reference Negro F (2010) Adverse effects of drugs in the treatment of viral hepatitis. Best Pract Res Clin Gastroenterol 24(2):183–192, ReviewPubMedCrossRef Negro F (2010) Adverse effects of drugs in the treatment of viral hepatitis. Best Pract Res Clin Gastroenterol 24(2):183–192, ReviewPubMedCrossRef
20.
go back to reference Stribling R, Sussman N, Vierling JM (2006) Treatment of hepatitis C infection. Gastroenterol Clin North Am 35(2):463–486PubMedCrossRef Stribling R, Sussman N, Vierling JM (2006) Treatment of hepatitis C infection. Gastroenterol Clin North Am 35(2):463–486PubMedCrossRef
21.
go back to reference Peeling RW, Hook EW 3rd (2006) The pathogenesis of syphilis: the Great Mimicker, revisited. J Pathol 208(2):224–232PubMedCrossRef Peeling RW, Hook EW 3rd (2006) The pathogenesis of syphilis: the Great Mimicker, revisited. J Pathol 208(2):224–232PubMedCrossRef
22.
23.
go back to reference Hook EW 3rd, Peeling RW (2004) Syphilis control—a continuing challenge. N Engl J Med 351(2):122–124PubMedCrossRef Hook EW 3rd, Peeling RW (2004) Syphilis control—a continuing challenge. N Engl J Med 351(2):122–124PubMedCrossRef
24.
go back to reference Marrazzo J (2007) Syphilis and other sexually transmitted diseases in HIV infection. Top HIV Med 15(1):11–16PubMed Marrazzo J (2007) Syphilis and other sexually transmitted diseases in HIV infection. Top HIV Med 15(1):11–16PubMed
25.
go back to reference Singh AE, Romanowski B (1999) Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12(2):187–209, reviewPubMed Singh AE, Romanowski B (1999) Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 12(2):187–209, reviewPubMed
27.
go back to reference Hewitt AB (1967) Syphilitic amyotrophy A case occurring after apparently successful treatment in primary syphilis. Br J Vener Dis 43(4):272–274PubMed Hewitt AB (1967) Syphilitic amyotrophy A case occurring after apparently successful treatment in primary syphilis. Br J Vener Dis 43(4):272–274PubMed
28.
go back to reference Wilson SAK (1911) Rev Neurolo Psychiat 9:401 Wilson SAK (1911) Rev Neurolo Psychiat 9:401
29.
go back to reference Etgen T, Bischoff C, Resch M, Winbeck K, Conrad B, Sander D (2003) Obstacles in the diagnosis and treatment of syphilitic amyotrophy. Neurology 60(3):509–511PubMed Etgen T, Bischoff C, Resch M, Winbeck K, Conrad B, Sander D (2003) Obstacles in the diagnosis and treatment of syphilitic amyotrophy. Neurology 60(3):509–511PubMed
30.
go back to reference Durston JH, Jefferiss FJ (1975) Syphilitic myositis. Br J Vener Dis 51(2):141–142PubMed Durston JH, Jefferiss FJ (1975) Syphilitic myositis. Br J Vener Dis 51(2):141–142PubMed
31.
go back to reference Nord J, Elemam A, Mandell W (2010) Myositis as an unusual presentation of secondary syphilis. S Med J 103(8):807–808CrossRef Nord J, Elemam A, Mandell W (2010) Myositis as an unusual presentation of secondary syphilis. S Med J 103(8):807–808CrossRef
32.
go back to reference de Carvalho MF, de Carvalho AF, Zyngier FR (1996) Syphilitic gumma. Trans R Soc Trop Med Hyg 90(5):548–549PubMedCrossRef de Carvalho MF, de Carvalho AF, Zyngier FR (1996) Syphilitic gumma. Trans R Soc Trop Med Hyg 90(5):548–549PubMedCrossRef
33.
go back to reference Amaratunge BC, Camuglia JE, Hall AJ (2010) Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin Experiment Ophthalmol 38(1):68–74, reviewPubMedCrossRef Amaratunge BC, Camuglia JE, Hall AJ (2010) Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin Experiment Ophthalmol 38(1):68–74, reviewPubMedCrossRef
34.
go back to reference Kent ME, Romanelli F (2008) Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother 42(2):226–236, Epub ReviewPubMedCrossRef Kent ME, Romanelli F (2008) Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother 42(2):226–236, Epub ReviewPubMedCrossRef
Metadata
Title
Syphilitic myositis: a case-based review
Authors
Elaine Yacyshyn
Praveena Chiowchanwisawakit
Derek J. Emery
Jack Jhamandas
Lothar Resch
Geoffrey Taylor
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 5/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-010-1668-z

Other articles of this Issue 5/2011

Clinical Rheumatology 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine